HLA
MYOK

Hamilton Lane Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Hamilton Lane Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-56,701
Closed -$3K – 58
2018
Q2 		$3K Buy
56,701
+15,445
+37% +$748K 2.73% 13
2018
Q1 		$2K Sell
41,256
-51,529
-56% -$2.68M 1.59% 27
2017
Q4 		$3.91M Buy
92,785
+53,186
+134% +$2.05M 2.02% 14
2017
Q3 		$1.7M Buy
+39,599
New +$1.26M 1.17% 20
2017
Q2 		– Sell
-37,287
Closed -$490K – 66
2017
Q1 		$490K Buy
37,287
+15,433
+71% +$198K 0.25% 47
2016
Q4 		$283K Buy
+21,854
New +$337K 0.19% 54

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return